The modifying effects of green tea polyphenols on acute colitis and inflammation-associated colon carcinogenesis in male ICR mice

BioFactors

Volumn 36, Issue 1, 2010, Pages 43-51

  Kim, Mihye ^a   Murakami, Akira ^a   Miyamoto, Shingo ^a   Tanaka, Takuji ^b   Ohigashi, Hajime ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Colitis; Colon carcinogenesis; Cytokines; Green tea polyphenols

Indexed keywords

INTERLEUKIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; POLYPHENOL;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLITIS; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA; TREATMENT FAILURE;

1,2-DIMETHYLHYDRAZINE; ANIMALS; COLITIS; COLONIC NEOPLASMS; DEXTRAN SULFATE; FLAVONOIDS; MALE; MICE; MICE, INBRED ICR; PHENOLS; TEA;

MUS;

EID: 77951116793     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.69     Document Type: Article

References (55)

1. Sun, C. L., Yuan, J. M., Koh, W. P., and Yu, M. C. (2006) Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27, 1310-1315.
2. Rice-Evans, C. A., Miller, N. J., and Paganga, G. (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20, 933-956.
3. Mazzon, E., Muia, C., Paola, R. D., Genovese, T., Menegazzi, M., De Sarro, A., Suzuki, H., and Cuzzocrea, S. (2005) Green tea polyphenol extract attenuates colon injury induced by experimental colitis. Free Radic. Res. 39, 1017-1025.
4. Na, H. K. and Surh, Y. J. (2006) Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. Mol. Nutr. Food Res. 50, 152-159.
5. Varilek, G. W., Yang, F., Lee, E. Y., deVilliers, W. J., Zhong, J., Oz, H. S., Westberry, K. F., and McClain, C. J. (2001) Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J. Nutr. 131, 2034-2039.
6. Yang, C. S., Maliakal, P., and Meng, X. (2002) Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42, 25-54.
7. Elbling, L., Weiss, R. M., Teufelhofer, O., Uhl, M., Knasmueller, S., Schulte-Hermann, R., Berger, W., and Micksche, M. (2005) Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J. 19, 807-809.
8. Hong, J., Lu, H., Meng, X., Ryu, J. H., Hara, Y., and Yang, C. S. (2002) Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 62, 7241-7246.
9. Fang, M. Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W., and Yang, C. S. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563-7570.
10. Murakami, A., Takahashi, D., Hagihara, K., Koshimizu, K., and Ohigashi, H. (2003) Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor-alpha in RAW264.7 murine macrophages. Biosci. Biotechnol. Biochem. 67, 1056-1062.
11. Park, J. W., Choi, Y. J., Suh, S. I., and Kwon, T. K. (2001) Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCGinduced cyclooxygenase-2 expression in Raw 264.7 cells. Biochem. Biophys. Res. Commun. 286, 721-725.
12. Kim, M., Murakami, A., Kawabata, K., and Ohigashi, H. (2005) (-)-Epigallocatechin- 3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis 26, 1553-1562.
13. Hinton, J. M. (1966) Risk of malignant change in ulcerative colitis. Gut 7, 427-432.
14. Itzkowitz, S. H. and Yio, X. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G7-17.
15. Kawanishi, S., Hiraku, Y., Pinlaor, S., and Ma, N. (2006) Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 387, 365-372.
16. Reinecker, H. C., Steffen, M., Witthoeft, T., Pflueger, I., Schreiber, S., MacDermott, R. P., and Raedler, A. (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94, 174-181.
17. Hirose, M., Hoshiya, T., Mizoguchi, Y., Nakamura, A., Akagi, K., and Shirai, T. (2001) Green tea catechins enhance tumor development in the colon without effects in the lung or thyroid after pretreatment with 1,2-Dimethylhydrazine or 2,2'-dihydroxy-di-n-propylnitrosamine in male F344 rats. Cancer Lett. 168, 23-29.
18. Hirose, M., Yamaguchi, T., Mizoguchi, Y., Akagi, K., Futakuchi, M., and Shirai, T. (2002) Lack of inhibitory effects of green tea catechins in 1,2-dimetylhydrazine-induced rat intestinal carcinogenesis model: comparison of the different formulations, administration routes and doses. Cancer Lett. 188, 163-170.
19. Kato, I., Tominaga, S., Matsuura, A., Yoshii, Y., Shirai, M., and Kobayashi, S. (1990) A comparative case-control study of colorectal cancer and adenoma. Jpn. J. Cancer Res. 81, 1101-1108.
20. Tajima, K. and Tominaga, S. (1985) Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn. J. Cancer Res. 76, 705-716.
21. Watanabe, Y., Tada, M., Kawamoto, K., Uozumi, G., Kajiwara, Y., Hayashi, K., Yamaguchi, K., Murakami, K., Misaki, F., Akasaka, Y., et al. (1984) [A case-control study of cancer of the rectum and colon]. Nippon Shokakibyo Gakkai Zasshi 81, 185-193.
22. Tsubono, Y., Nishino, Y., Komatsu, S., Hsieh, C. C., Kanemura, S., Tsuji, I., Nakatsuka, H., Fukao, A., Satoh, H., and Hisamichi, S. (2001) Green tea and the risk of gastric cancer in Japan. N. Engl. J. Med. 344, 632-636.
23. Yang, C. S. and Wang, Z. Y. (1993) Tea and cancer. J. Natl. Cancer Inst. 85, 1038-1049.
24. Babbs, C. F. (1992) Oxygen radicals in ulcerative colitis. Free Radic. Biol. Med. 13, 169-181.
25. State, D. and Hill, G. S. (1976) Asymptomatic primary hyperparathyroidism. Am. J. Surg. 132, 231-235.
26. Ohkawara, T., Takeda, H., Nishihira, J., Miyashita, K., Nihiwaki, M., Ishiguro, Y., Takeda, K., Akira, S., Iwanaga, T., Sugiyama, T., and Asaka, M. (2005) Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice. Clin. Exp. Immunol. 141, 412-421.
27. Arai, Y., Takanashi, H., Kitagawa, H., and Okayasu, I. (1998) Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 10, 890-896.
28. Halliwell, B. (1996) Antioxidants in human health and disease. Annu. Rev. Nutr. 16, 33-50.
29. Kohno, H., Suzuki, R., Sugie, S., and Tanaka, T. (2005) Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate. Cancer Sci. 96, 69-76.
30. Cooper, H. S., Murthy, S. N., Shah, R. S., and Sedergran, D. J. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249.
31. Perdue, M. H., Ramage, J. K., Burget, D., Marshall, J., and Masson, S. (1989) Intestinal mucosal injury is associated with mast cell activation and leukotriene generation during Nippostrongylus-induced inflammation in the rat. Dig. Dis. Sci. 34, 724-731.
32. Alrawi, S. J., Schiff, M., Carroll, R. E., Dayton, M., Gibbs, J. F., Kulavlat, M., Tan, D., Berman, K., Stoler, D. L., and Anderson, G. R. (2006) Aberrant crypt foci. Anticancer Res. 26, 107-119.
33. Cheng, L. and Lai, M. D. (2003) Aberrant crypt foci as microscopic precursors of colorectal cancer. World J. Gastroenterol. 9, 2642-2649.
34. Ward, J. M. (1974) Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest. 30, 505-513.
35. Lin, J. K., Chen, P. C., Ho, C. T., and Lin-Shiau, S. Y. (2000) Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,30-digallate, (-)-epigallocatechin-3- gallate, and propyl gallate. J. Agric. Food Chem. 48, 2736-2743.
36. Blot, W. J., Chow, W. H., and McLaughlin, J. K. (1996) Tea and cancer: a review of the epidemiological evidence. Eur. J. Cancer Prev. 5, 425-438.
37. Kohlmeier, L., Weterings, K. G., Steck, S., and Kok, F. J. (1997) Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr. Cancer 27, 1-13.
38. Bushman, J. L. (1998) Green tea and cancer in humans: a review of the literature. Nutr. Cancer 31, 151-159.
39. Weisburger, J. H., Rivenson, A., Aliaga, C., Reinhardt, J., Kelloff, G. J., Boone, C. W., Steele, V. E., Balentine, D. A., Pittman, B., and Zang, E. (1998) Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer. Proc. Soc. Exp. Biol. Med. 217, 104-108.
40. Lambert, J. D., Lee, M. J., Diamond, L., Ju, J., Hong, J., Bose, M., Newmark, H. L., and Yang, C. S. (2006) Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 34, 8-11.
41. Lambert, J. D., Lee, M. J., Lu, H., Meng, X., Hong, J. J., Seril, D. N., Sturgill, M. G., and Yang, C. S. (2003) Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr. 133, 4172-4177.
42. Jatoi, A., Ellison, N., Burch, P. A., Sloan, J. A., Dakhil, S. R., Novotny, P., Tan, W., Fitch, T. R., Rowland, K. M., Young, C. Y., and Flynn, P. J. (2003) A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97, 1442-1446.
43. Chow, H. H., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y., and Alberts, D. S. (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 9, 3312-3319.
44. Yamane, T., Hagiwara, N., Tateishi, M., Akachi, S., Kim, M., Okuzumi, J., Kitao, Y., Inagake, M., Kuwata, K., and Takahashi, T. (1991) Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn. J. Cancer Res. 82, 1336-1339.
45. Shkolnik, T., Livni, E., Reshef, R., Lachter, J., and Eidelman, S. (1987) Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions. Am. J. Gastroenterol. 82, 1275-1278.
46. Brannigan, A. E., O'Connell, P. R., Hurley, H., O'Neill, A., Brady, H. R., Fitzpatrick, J. M., and Watson, R. W. (2000) Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13, 361-366.
47. Karlsson, P. C., Huss, U., Jenner, A., Halliwell, B., Bohlin, L., and Rafter, J. J. (2005) Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds. J. Nutr. 135, 2343-2349.
48. Entleutner, M., Traeger, T., Westerholt, A., Holzmann, B., Stier, A., Pfeffer, K., Maier, S., and Heidecke, C. D. (2006) Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis. Int. J. Colorectal Dis. 21, 64-70.
49. Barksby, H. E., Lea, S. R., Preshaw, P. M., and Taylor, J. J. (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149, 217-225.
50. Ferrero-Miliani, L., Seidelin, J. B., and Nielsen, O. H. (2006) [Regulation of cytokine production in inflammatory bowel disease]. Ugeskr Laeger 168, 1847-1850.
51. Abboud, P. A., Hake, P. W., Burroughs, T. J., Odoms, K., O'Connor, M., Mangeshkar, P., Wong, H. R., and Zingarelli, B. (2008) Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur J. Pharmacol. 579, 411-417.
52. Ran, Z. H., Chen, C., and Xiao, S. D. (2008) Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed. Pharmacother. 62, 189-196.
53. Kwon, K. H., Murakami, A., Hayashi, R., and Ohigashi, H. (2005) Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem. Biophys. Res. Commun. 337, 647-654.
54. Kruidenier, L. and Verspaget, H. W. (2002) Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment. Pharmacol. Ther. 16, 1997-2015.
55. Rahman, I. (2000) Regulation of nuclear factor-kappa B, activator protein- 1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells. Biochem. Pharmacol. 60, 1041-1049.